This is a non-core endpoint: only basic statistics are computed.
Secondary malignant neoplasm of other and unspecified sites
C3_SECONDARY_NAS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
628 |
4. Check minimum number of eventsNone |
628 |
5. Include endpointsNone |
628 |
6. Filter based on genotype QC (FinnGen only) |
610 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Secondary malignant neoplasm of other and unspecified sites
based on the number of shared cases.
Similar with more cases:
- Secondary uncertain malignant neoplasm
- Secondary malignant neoplasm of other and unspecified sites, including Hilmo
- Any death
- Solid cancers, helper endpoint
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 610 | 262 | 348 |
| Unadjusted period prevalence (%) | 0.13 | 0.09 | 0.16 |
| Median age at first event (years) | 72.65 | 70.33 | 74.40 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 628
- Matched controls
- 6280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N02AA05
ATC
oxycodone; systemic
22.5
307.7
436
575
XX3DW
NOMESCO Finland
Time consuming IT work
39.2
307.7
302
145
JN4BD
NOMESCO Finland
Extensive body CT
36.7
307.7
286
140
H02AB02
ATC
dexamethasone; systemic
420.9
307.7
429
32
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
347
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
307.7
352
*
Z51.5
ICD-10 Finland
Palliative care
82.2
307.7
376
112
A03FA01
ATC
metoclopramide; systemic, rectal
33.5
307.7
437
402
WF049
NOMESCO Finland
Radiotherapy of metastasis
5132.9
307.7
301
*
JN4AD
NOMESCO Finland
Body CT examination
19.9
266.4
243
193
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
260.0
231
*
A04AA02
ATC
granisetron; systemic, transdermal
3286.8
257.7
231
*
A04AA01
ATC
ondansetron; systemic, rectal
43.1
255.4
159
49
WZC00
NOMESCO Finland
Treatment plan or consultation
14.0
237.2
462
1042
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
40.3
228.2
144
46
M05BX04
ATC
denosumab; parenteral
17.9
210.7
194
153
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1344.1
205.2
189
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
666.2
201.8
189
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
200.0
181
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
165.1
151
*
JN4CD
NOMESCO Finland
Very extensive body CT
33.0
148.5
98
35
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
143.4
132
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
143.4
132
*
L01BC06
ATC
capecitabine; oral
+∞
137.7
127
*
116
Kela drug reimbursment
Prostate cancer
+∞
132.1
122
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
379.5
125.2
122
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
21.8
119.2
92
49
WW500
NOMESCO Finland
Blood transfusion
20.2
118.5
95
55
A06AH03
ATC
naloxegol; oral
61.3
117.7
66
12
WZC30
NOMESCO Finland
Teaching
7.3
113.7
215
419
115
Kela drug reimbursment
Breast cancer
+∞
109.7
102
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
603.9
106.0
102
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
90.9
85
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
31.8
88.0
58
20
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
332.6
87.0
86
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
17.8
86.9
73
46
L02AE02
ATC
leuprorelin; implant, parenteral
251.9
86.8
87
*
L03AA13
ATC
pegfilgrastim; parenteral
328.0
85.9
85
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
85.4
80
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
81.0
76
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
15.5
80.5
73
53
L02BG04
ATC
letrozole; oral
440.4
79.8
78
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
860.8
79.2
76
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
77.7
73
*
HA1AA
NOMESCO Finland
X-ray mammography
13.2
77.0
77
66
PJA12
NOMESCO Finland
Sentinel node biopsy
822.3
75.9
73
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
75.6
71
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
74.5
70
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
74.5
70
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.6
73.7
171
392
Y77
ICPC
Malignant neoplasm prostate
784.1
72.7
70
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
72.3
68
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
71.2
67
*
WF002
NOMESCO Finland
Radical radiotherapy
139.5
70.6
74
6
B01AB10
ATC
tinzaparin; parenteral
6.5
69.0
128
237
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
721.4
67.3
65
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
18.4
65.9
54
32
L02BB03
ATC
bicalutamide; oral
+∞
63.6
60
*
L02BB04
ATC
enzalutamide; oral
+∞
63.6
60
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
62.6
59
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
339.7
61.5
61
*
A04AD12
ATC
aprepitant; systemic
+∞
60.4
57
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
60.4
57
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
59.3
56
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
13.0
57.3
57
48
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
55.0
52
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.4
55.0
56
49
L02BA01
ATC
tamoxifen; oral
295.5
54.1
54
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
53.9
51
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
53.9
51
*
N02AA01
ATC
morphine; systemic, rectal
17.2
53.4
45
28
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
52.9
50
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
51.8
49
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
50.7
48
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
144.4
50.6
53
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
271.1
49.8
50
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
49.6
47
*
L02BX03
ATC
abiraterone; oral
+∞
48.6
46
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.3
47.8
302
1368
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
47.6
416
2282
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
5.1
46.0
110
253
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
44.3
42
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
43.2
41
*
L01CA04
ATC
vinorelbine; systemic
+∞
43.2
41
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
434.9
41.6
41
*
X76
ICPC
Malignant neoplasm breast female
+∞
41.1
39
*
L02BX02
ATC
degarelix; parenteral
+∞
41.1
39
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
423.5
40.6
40
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
115.2
40.3
43
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
14.5
40.2
37
27
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
40.0
38
*
L02BA03
ATC
fulvestrant; parenteral
+∞
40.0
38
*
N03AX14
ATC
levetiracetam; systemic
8.8
39.9
52
64
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.5
39.5
111
289
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
39.0
37
*
192
Kela drug reimbursment
Fulvestrant
+∞
39.0
37
*
A79
ICPC
Malignancy NOS
400.7
38.5
38
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.8
38.3
95
224
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
37.9
36
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
37.9
36
*
L03AA02
ATC
filgrastim; parenteral
138.4
37.1
39
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
14.3
36.8
34
25
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
378.0
36.4
36
*
ZX120
NOMESCO Finland
Intravenous
4.9
36.3
88
203
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.7
36.2
92
221
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
35.8
34
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.9
33.5
111
325
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.4
33.2
70
143
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
7.4
32.7
49
71
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
32.6
31
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
32.6
31
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
32.6
31
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
32.6
31
*
JN6AD
NOMESCO Finland
CT of torso and neck
36.4
32.3
41
12
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.1
32.0
6
928
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
31.5
30
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
31.5
30
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
63.5
31.4
36
6
A02BC02
ATC
pantoprazole; systemic
3.1
31.3
495
3410
B01AB05
ATC
enoxaparin; parenteral
2.7
30.0
258
1306
L02AE03
ATC
goserelin; implant
162.8
29.9
31
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
29.4
28
*
1501
Kela drug reimbursment
Palbociclib
+∞
29.4
28
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
29.4
28
*
L02BG06
ATC
exemestane; oral
305.4
29.0
29
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
28.3
27
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
56.0
27.4
32
6
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
56.0
27.4
32
6
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
27.3
26
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
27.3
26
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
27.1
118
411
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
9.1
26.5
33
38
H02AB06
ATC
prednisolone; systemic
2.5
26.4
362
2241
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
26.2
25
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
26.2
25
*
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
26.2
25
*
L01CB01
ATC
etoposide; systemic
+∞
26.2
25
*
SPAT1254
SPAT
Administration of medicine
2.9
26.1
149
605
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
25.2
24
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
25.2
24
*
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
+∞
25.2
24
*
ZX112
NOMESCO Finland
Subcutaneous
27.6
25.1
34
13
R50.9
ICD-10 Finland
Fever, unspecified
3.1
25.0
124
465
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
24.7
194
926
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
24.1
23
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
24.1
23
*
J01MA12
ATC
levofloxacin; systemic
2.7
23.8
164
732
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
10.0
23.4
27
28
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
56.3
23.2
27
5
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.6
23.1
82
249
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
23.1
22
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
23.1
22
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
23.1
22
*
L01XE33
ATC
[U] palbociclib
+∞
23.1
22
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
33.7
22.6
29
9
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.3
22.4
326
2022
J94.8
ICD-10 Finland
Other specified pleural conditions
8.2
22.3
30
38
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.2
22.1
63
164
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
22.1
110
412
TGD00
NOMESCO Finland
Needle biopsy of lung
65.0
22.0
25
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
22.0
21
*
394
Kela drug reimbursment
Palbociclib
+∞
22.0
21
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
119.2
21.7
23
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
6.7
21.1
34
53
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
+∞
20.9
20
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
20.9
20
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
79.6
20.8
23
*
SPAT1109
SPAT
Analgesia with portable analgesic pump
79.6
20.8
23
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.7
20.7
50
114
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
19.9
19
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
19.9
19
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
19.9
19
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
5.3
19.8
41
82
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.9
19.7
31
47
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
32.5
19.4
25
8
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
6.3
19.2
33
55
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.3
19.1
51
126
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
18.8
18
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
18.8
18
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
18.8
18
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
18.8
18
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
18.8
18
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
18.8
18
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
18.8
18
*
WW200, ,
SPAT
0.2
18.6
21
1082
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.9
18.2
33
58
WF099
NOMESCO Finland
Other radiotherapy
68.7
17.8
20
*
L02AE04
ATC
triptorelin; parenteral
+∞
17.8
17
*
1523, ,
Kela drug reimbursment
+∞
17.8
17
*
3054, ,
Kela drug reimbursment
+∞
17.8
17
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
17.8
17
*
L02BG03
ATC
anastrozole; oral
+∞
17.8
17
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
17.8
17
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
185.0
17.6
18
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
29.8
17.5
23
8
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
17.3
149
727
EB1VA, ,
NOMESCO Finland
0.0
17.3
*
409
NF3AA
NOMESCO Finland
Femur X-ray examination
5.5
17.2
34
65
AA1AD
NOMESCO Finland
CT of head and brain
2.1
17.2
238
1409
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
36.1
16.8
21
6
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
16.7
16
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
16.7
16
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
16.7
16
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
16.7
16
*
TKE00
NOMESCO Finland
Needle biopsy of prostate
5.2
16.6
35
71
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
174.4
16.6
17
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
41.3
16.4
20
5
SPAT1255
SPAT
Intravenous administration of medicine
3.3
16.4
67
222
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.5
16.2
41
97
KCD02
NOMESCO Finland
Transurethral resection of bladder
31.0
16.2
21
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
16.2
125
580
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
15.7
15
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
15.7
15
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
15.7
15
*
197
Kela drug reimbursment
Sunitinib
+∞
15.7
15
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
15.7
15
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
15.7
148
749
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
14.2
15.6
26
19
ZX050
NOMESCO Finland
Stereotactic radiotherapy
163.9
15.5
16
*
Z51.0
ICD-10 Finland
Radiotherapy session
163.9
15.5
16
*
R84
ICPC
Malignant neoplasm bronchus/lung
163.9
15.5
16
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
163.9
15.5
16
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
39.1
15.5
19
5
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.6
15.4
37
84
N02BE01
ATC
paracetamol; systemic, rectal
3.2
15.1
577
4907
A06AD11
ATC
lactulose; oral
2.4
15.0
126
606
SPAT1262
SPAT
Handing over of treatment supplies
2.2
14.9
149
770
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
58.1
14.8
17
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
+∞
14.6
14
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
14.6
14
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
14.6
14
*
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
14.6
14
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
14.6
14
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
14.6
14
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
14.6
14
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
14.6
14
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
14.6
14
*
N03AX16
ATC
[U] pregabalin
2.1
14.5
172
950
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
37.0
14.5
18
5
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
13.8
14.3
24
18
GD1AD
NOMESCO Finland
Thorax CT examination
3.4
14.3
53
165
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.9
14.1
43
117
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.7
14.0
46
132
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
13.7
204
1220
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
13.6
13
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
13.6
13
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
13.6
13
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
13.6
13
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
13.6
13
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
13.6
13
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
143.0
13.5
14
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
143.0
13.5
14
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
143.0
13.5
14
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
17.2
13.1
20
12
XKD00
NOMESCO Finland
Uroflowmetry
2.2
13.0
129
661
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
51.1
12.9
15
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
12.7
152
837
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
12.7
79
329
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
71.3
12.6
14
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
32.8
12.6
16
5
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.5
293
2019
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.4
12.5
21
34
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
12.5
12
*
159
Kela drug reimbursment
Pazopanib
+∞
12.5
12
*
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
+∞
12.5
12
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
12.5
12
*
L01AX03
ATC
temozolomide; systemic
+∞
12.5
12
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
12.5
12
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
12.5
12
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
12.5
12
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
12.5
12
*
L01XE04
ATC
[U] sunitinib
+∞
12.5
12
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
27.3
12.1
16
6
C03CA01
ATC
furosemide; systemic
1.9
12.0
242
1588
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
12.0
115
581
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.2
11.8
23
854
180
Kela drug reimbursment
Interferon alfa
+∞
11.5
11
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
11.5
11
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
11.5
11
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
11.5
11
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
11.5
11
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
11.5
11
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
11.5
11
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
11.5
11
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
11.5
11
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
11.5
11
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
11.5
11
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
11.5
11
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.1
11.5
48
161
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
122.2
11.5
12
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
122.2
11.5
12
*
D77
ICPC
Malignant digestive neopl other/NOS
122.2
11.5
12
*
EB4VA, ,
NOMESCO Finland
0.0
11.4
*
275
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.3
11.3
23
45
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
5.3
11.3
23
45
C10AA07
ATC
rosuvastatin; oral
0.4
11.2
82
1600
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
25.5
11.2
15
6
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
25.5
11.2
15
6
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
11.0
103
515
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
44.1
11.0
13
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
44.1
11.0
13
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
44.1
11.0
13
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
10.9
150
864
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
10.8
54
201
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
28.6
10.8
14
5
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
61.1
10.7
12
*
S77
ICPC
Malignant neoplasm of skin
61.1
10.7
12
*
R18
ICD-10 Finland
Ascites
5.4
10.7
21
40
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
10.6
84
391
TQB05
NOMESCO Finland
Puncture of skin of trunk
111.8
10.4
11
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
10.4
10
*
176
Kela drug reimbursment
Regorafenib
+∞
10.4
10
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
10.4
10
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
+∞
10.4
10
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
10.4
10
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
10.4
10
*
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
+∞
10.4
10
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
10.4
10
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
10.4
10
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
10.4
10
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
10.4
10
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
10.4
10
*
L01BC59
ATC
trifluridine, combinations; systemic
+∞
10.4
10
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
10.4
10
*
L01XE11
ATC
[U] pazopanib
+∞
10.4
10
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
12.3
10.4
18
15
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.5
10.3
36
108
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.7
10.3
58
230
B03XA02
ATC
darbepoetin alfa; parenteral
5.4
10.2
20
38
N05CF01
ATC
zopiclone; oral
1.8
10.1
218
1445
UKC02
NOMESCO Finland
Cystoscopy
2.0
10.0
117
635
D75
ICPC
Malignant neoplasm colon/rectum
40.8
10.0
12
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
40.8
10.0
12
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.8
10.0
22
29
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
8.3
9.9
21
26
JG1BG
NOMESCO Finland
MRI of rectum
55.9
9.7
11
*
KA3EB
NOMESCO Finland
Antegrade pyelography
55.9
9.7
11
*
C10AA05
ATC
atorvastatin; oral
0.5
9.6
161
2422
C10AX09
ATC
ezetimibe; oral
0.3
9.6
25
794
SPAT1263
SPAT
Sampling
1.7
9.6
266
1885
NF1AA
NOMESCO Finland
Hip X-ray examination
2.3
9.5
79
375
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.4
9.5
71
322
XX1AD
NOMESCO Finland
Other CT-examination
101.5
9.4
10
*
GDC00
NOMESCO Finland
Lobectomy of lung
101.5
9.4
10
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
30.5
9.4
12
*
JFF23
NOMESCO Finland
Transversostomy
30.5
9.4
12
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
12.6
9.4
16
13
ZXC96
NOMESCO Finland
Robot assisted procedure
12.6
9.4
16
13
1CD02, ,
NOMESCO Finland
+∞
9.4
9
*
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
9.4
9
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
9.4
9
*
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
+∞
9.4
9
*
C80.9
ICD-10 Finland
Malignant neoplasm, primary site unspecified
+∞
9.4
9
*
3016
Kela drug reimbursment
Binimetinib and encorafenib
+∞
9.4
9
*
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
9.4
9
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
9.4
9
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
9.4
9
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
+∞
9.4
9
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
+∞
9.4
9
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
9.4
9
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
9.4
9
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
9.4
9
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
9.4
9
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
+∞
9.4
9
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
9.4
9
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
9.4
9
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
9.4
9
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
9.4
9
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
9.4
79
377
J01DB01
ATC
cefalexin; oral
1.9
9.3
498
4214
N05BA04
ATC
oxazepam; oral
1.8
9.3
168
1052
B01AB04
ATC
dalteparin; parenteral
3.2
9.2
37
121
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.4
9.2
33
101
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
9.2
9.1
18
20
R4110, ,
SPAT
0.1
9.0
5
351
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
18.9
9.0
13
7
Z31.5
ICD-10 Finland
Genetic counselling
4.4
8.9
22
51
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.0
8.9
39
135
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
50.7
8.7
10
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
8.7
122
704
ZZR00
NOMESCO Finland
Flap of skin
16.6
8.6
13
8
N05BA06
ATC
lorazepam; systemic, sublingual
2.7
8.6
45
172
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
8.5
297
2215
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
91.2
8.4
9
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
91.2
8.4
9
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
91.2
8.4
9
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
91.2
8.4
9
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
8.3
8
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
8.3
8
*
1513
Kela drug reimbursment
Binimetinib and encorafenib
+∞
8.3
8
*
L01XE23
ATC
[U] dabrafenib
+∞
8.3
8
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.3
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.3
8
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
8.3
8
*
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
+∞
8.3
8
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
8.3
8
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
8.3
8
*
L01BC53
ATC
tegafur, combinations; systemic
+∞
8.3
8
*
369
Kela drug reimbursment
Regorafenib
+∞
8.3
8
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
8.3
8
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
8.3
8
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
8.3
8
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
8.3
8
*
C43.4
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of scalp and neck
+∞
8.3
8
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
8.3
8
*
KEB00
NOMESCO Finland
Biopsy of prostate
9.6
8.3
16
17
SPAT1301
SPAT
No procedures
1.7
8.2
215
1485
SPAT1111
SPAT
Planning of analgesia
8.3
8.1
17
21
E83.50
ICD-10 Finland
Hypercalcemia
8.3
8.1
17
21
KA1FN
NOMESCO Finland
Isotope renography
17.4
8.1
12
7
OAB42, ,
SPAT
0.2
8.1
7
365
A07AA02
ATC
nystatin; oral
2.6
8.0
45
178
N02BF01
ATC
gabapentin; oral
0.1
8.0
*
304
R83
ICPC
Respiratory infection other
0.3
8.0
21
665
SPAT1104
SPAT
Monitoring of emergency patient
2.5
8.0
50
209
XJH00
NOMESCO Finland
Transanal ultrasonography
2.6
7.8
47
193
R11
ICD-10 Finland
Nausea and vomiting
2.3
7.7
58
263
SPAT1153
SPAT
Removal of sutures
1.7
7.7
206
1426
JFB30
NOMESCO Finland
Right hemicolectomy
15.3
7.7
12
8
L17
ICPC
Foot/toe symptom/complaint
0.5
7.7
71
1303
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.3
7.6
19
31
E0000UV, ,
ATC
1.6
7.5
231
1655
A28
ICPC
Limited function/disability NOS
1.8
7.5
138
862
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
7.5
215
1515
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.6
7.5
24
68
R31
ICD-10 Finland
Unspecified haematuria
2.0
7.5
80
419
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
81.0
7.4
8
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
7.8
7.4
16
21
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.8
7.4
22
59
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.0
7.4
32
110
SPAT1167
SPAT
Insertion of urinary catheter
3.1
7.3
31
105
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
11.0
7.3
13
12
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
+∞
7.3
7
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
7.3
7
*
155
Kela drug reimbursment
Afatinib and gefitinib
+∞
7.3
7
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
7.3
7
*
XX7AT
NOMESCO Finland
Radiation therapy with Radium-223
+∞
7.3
7
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
7.3
7
*
198
Kela drug reimbursment
Sorafenib
+∞
7.3
7
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
7.3
7
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
7.3
7
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
7.3
7
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
7.3
7
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
7.3
7
*
L01XE25
ATC
[U] trametinib
+∞
7.3
7
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
7.3
7
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
7.3
7
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
7.3
7
*
C16.0
ICD-10 Finland
Malignant neoplasm: Cardia
+∞
7.3
7
*
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
+∞
7.3
7
*
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
7.3
7
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
7.3
7
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
7.3
7
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
7.3
7
*
3012
Kela drug reimbursment
Cabozantinib
+∞
7.3
7
*
R4190
NOMESCO Finland
Nutritional therapy
4.4
7.3
18
42
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
7.2
35
128
SPAT1304
SPAT
Counselling and guidance related to ageing
2.1
7.2
68
339
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
30.4
7.2
9
*
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
20.3
7.1
10
5
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.6
7.0
23
66
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
3.6
7.0
23
66
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.5
7.0
17
39
WX110, ,
SPAT
0.0
6.8
*
167
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
40.5
6.8
8
*
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
40.5
6.8
8
*
TJA10
NOMESCO Finland
Laparocentesis
40.5
6.8
8
*
A41.8
ICD-10 Finland
Other specified sepsis
4.0
6.8
19
49
TJF80
NOMESCO Finland
Ostomy education
22.8
6.7
9
*
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
22.8
6.7
9
*
A98
ICPC
Health maint/preventive medicine
0.6
6.6
502
5486
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
12.4
6.6
11
9
HAB99
NOMESCO Finland
Other partial excision of mammary gland
12.4
6.6
11
9
WX600
NOMESCO Finland
Single shot through catheter
10.2
6.6
12
12
A41.9
ICD-10 Finland
Sepsis, unspecified
2.9
6.5
30
107
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
70.5
6.4
7
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
70.5
6.4
7
*
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
14.5
6.4
10
7
OAA67, ,
SPAT
0.1
6.3
*
235
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.9
6.3
18
47
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
6.3
6
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
6.3
6
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
L01XE21
ATC
[U] regorafenib
+∞
6.3
6
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
6.3
6
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
6.3
6
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
+∞
6.3
6
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
6.3
6
*
168
Kela drug reimbursment
Axitinib
+∞
6.3
6
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
6.3
6
*
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
+∞
6.3
6
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
6.3
6
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
6.3
6
*
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
6.3
6
*
C80.98
ICD-10 Finland
Malignant tumor without specified localization other specified histology
+∞
6.3
6
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
6.3
6
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
+∞
6.3
6
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
6.3
6
*
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
+∞
6.3
6
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.3
6
*
1502
Kela drug reimbursment
Cabozantinib
+∞
6.3
6
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
6.3
6
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
6.3
6
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
6.3
6
*
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
+∞
6.3
6
*
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
+∞
6.3
6
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
6.3
6
*
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
+∞
6.3
6
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
6.3
6
*
L15
ICPC
Knee symptom/complaint
0.5
6.3
55
1035
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
5.4
6.2
17
32
TKC22
NOMESCO Finland
Catheterisation instruction
3.5
6.2
21
62
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.9
6.2
28
99
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
7.8
6.1
13
17
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
7.8
6.1
13
17
OAB43, ,
SPAT
0.2
6.1
10
420
G47.3
ICD-10 Finland
Sleep apnoea
0.5
6.1
53
1004
PJA10
NOMESCO Finland
Exploration of lymph nodes
12.7
6.1
10
8
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.7
6.1
12
14
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
6.1
6.0
15
25
TDA90, ,
SPAT
0.1
6.0
*
227
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
266
259
17.08
258.51
5.4
1.5
87.97
2.68
ug/l
2.95
250
197
98
49
23.51
130.77
4.7
1.7
1660.24
35.61
u/ml
1.59
90
42
532
2411
8.89
109.82
17.1
3.9
9.90
12.12
umol/l
3.78
522
2258
275
746
5.78
101.11
5.1
2.5
0.81
0.82
mmol/l
1.59
269
689
515
2634
6.31
81.25
19.5
6.2
4.64
4.37
e9/l
1.30
487
2278
505
2545
6.03
81.03
11.3
5.5
1.22
1.21
mmol/l
0.64
373
2196
72
58
13.89
74.74
1.2
1.2
—
—
—
0
0
120
211
6.79
67.99
2.1
1.8
3.10
2.11
ug/l
0.23
114
185
460
2335
4.63
67.96
8.9
5.1
1.22
1.21
mmol/l
1.62
445
2077
466
2591
4.10
55.55
11.5
18.0
1.22
1.38
inr
4.85
166
738
419
2188
3.75
54.62
5.9
3.7
30.51
35.41
g/l
38.93
404
2008
54
45
13.03
54.62
1.9
3.3
2.97
1.34
%
1.22
47
38
72
92
8.71
53.85
2.7
2.2
1072.26
69.58
u/ml
1.27
65
71
346
1653
3.43
50.89
6.6
2.0
2.32
2.35
mmol/l
2.51
324
1356
327
1581
3.23
45.82
3.3
2.2
51.95
60.63
u/l
1.59
312
1441
50
50
10.78
44.79
1.1
1.1
—
—
—
0
0
47
5
101.47
43.42
5.0
1.0
101.38
15.80
u/ml
—
47
5
559
3828
5.19
43.09
20.5
5.3
123.74
75.95
u/l
13.66
543
3508
490
3073
3.71
43.00
6.6
4.3
6.84
6.86
mmol/l
0.07
475
2883
380
2176
2.89
36.53
3.1
2.3
—
—
—
0
0
150
522
3.46
35.05
5.9
2.9
—
—
—
0
0
378
2196
2.81
34.70
4.2
4.0
39.80
78.67
ng/l
0.87
344
1645
202
870
2.95
32.59
1.9
1.8
—
—
—
0
0
380
2261
2.72
32.48
5.3
5.5
19.44
26.68
%
29.82
359
2096
485
3316
3.03
30.84
5.2
4.4
75.31
3162.27
e6/l
1.60
13
55
50
81
6.62
30.05
4.1
3.0
62.68
58.47
%
1.07
50
81
57
106
5.81
29.84
1.2
1.4
—
—
—
0
0
368
2215
2.60
29.76
4.9
5.4
2.01
3.02
%
14.36
345
2048
54
97
6.00
29.30
1.2
1.5
—
—
—
0
0
24
1463
0.13
28.74
1.3
1.6
1.40
1.34
mmol/l
0.26
18
1207
72
170
4.65
28.72
2.3
3.4
—
—
—
0
0
52
97
5.75
27.10
1.3
1.5
—
—
—
0
0
47
81
6.19
26.56
3.6
2.7
4.09
4.50
e9/l
0.45
47
81
44
73
6.41
25.80
1.2
1.4
—
—
—
0
0
375
4934
0.40
25.67
5.1
6.5
42.91
40.74
mmol/mol
1.04
325
4524
79
218
4.00
25.65
2.1
1.7
—
—
—
0
0
416
5226
0.40
24.74
3.4
5.5
2.66
2.61
mmol/l
0.50
353
4754
395
5054
0.41
23.88
3.2
4.9
1.39
1.45
mmol/l
1.57
338
4582
403
5113
0.41
23.79
3.3
4.9
4.52
4.49
mmol/l
0.24
347
4664
247
1341
2.39
23.52
4.2
3.9
0.00
0.01
estimate
0.50
102
394
352
2247
2.29
22.62
4.9
5.3
65.36
58.10
%
21.96
335
2084
72
204
3.86
22.46
2.0
1.6
—
—
—
0
0
89
319
3.09
19.15
1.5
1.5
—
—
—
0
0
30
20
15.69
18.61
3.1
1.6
11.03
3.34
nmol/l
1.25
30
20
204
1122
2.21
17.92
2.8
2.1
—
—
—
0
0
27
41
6.84
17.15
1.1
1.1
—
—
—
0
0
27
41
6.84
17.15
1.1
1.1
—
—
—
0
0
27
41
6.84
17.15
1.1
1.1
—
—
—
0
0
50
132
4.03
17.14
1.8
1.5
—
—
—
0
0
89
341
2.88
16.94
1.6
1.5
—
—
—
0
0
291
1868
2.04
16.75
4.7
3.9
—
—
—
0
0
35
71
5.16
16.59
1.1
1.4
—
—
—
0
0
35
71
5.16
16.59
1.1
1.4
—
—
—
0
0
35
72
5.09
16.33
1.2
1.3
—
—
—
0
0
32
61
5.47
16.24
1.2
1.5
—
—
—
0
0
396
4883
0.49
15.70
3.1
4.3
1.34
1.27
mmol/l
1.46
337
4379
29
52
5.80
15.68
1.2
1.6
13668.64
161550.55
e6/l
0.67
22
31
584
4990
3.43
15.40
31.6
13.5
41.05
24.91
mg/l
21.10
560
3868
44
115
4.04
15.28
2.0
2.3
15.87
16.27
%
0.16
18
58
86
344
2.74
15.04
2.7
3.6
2.68
2.08
mmol/l
0.50
66
255
36
82
4.60
14.91
1.2
1.4
—
—
—
0
0
180
1003
2.11
14.88
7.0
2.1
2.51
2.44
mmol/l
4.72
164
854
14
0
+∞
14.64
1.1
0.0
—
—
—
0
0
88
362
2.66
14.56
2.7
3.7
5.17
5.20
kpa
0.07
83
348
31
64
5.04
14.41
1.2
1.4
—
—
—
0
0
26
47
5.73
13.94
1.1
1.2
—
—
—
0
0
21
12
18.06
13.91
1.8
2.0
—
—
—
0
0
22
34
6.67
13.73
2.2
3.4
64.47
54.79
%
1.28
17
28
183
1055
2.04
13.64
2.4
2.4
8.12
4.83
e6/l
2.02
170
949
153
826
2.13
13.60
1.9
1.9
29.22
29.91
s
0.60
147
790
130
660
2.22
13.48
4.1
4.5
1.00
1.03
mmol/l
0.37
122
593
275
1846
1.87
12.90
3.2
3.0
—
—
—
0
0
24
44
5.63
12.68
1.1
1.3
—
—
—
0
0
23
21
11.32
12.61
1.4
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
49
158
3.28
12.50
2.1
2.5
0.38
0.33
u/ml
0.53
37
97
29
67
4.49
11.81
2.0
1.6
90.52
90.31
%
0.09
29
67
29
68
4.42
11.59
1.2
1.3
—
—
—
0
0
21
37
5.84
11.54
1.3
1.5
—
—
—
0
0
11
0
+∞
11.49
1.0
0.0
—
—
—
0
0
335
2472
1.76
10.86
4.4
3.7
0.00
0.01
estimate
0.50
114
401
90
436
2.24
10.32
2.4
1.6
64.75
67.21
g/l
2.16
81
393
23
49
4.83
10.31
1.3
1.6
—
—
—
0
0
254
1759
1.75
10.08
2.2
2.2
167.27
269.70
u/l
1.27
240
1638
327
2434
1.72
9.95
5.6
5.0
0.00
0.00
estimate
-0.00
113
406
259
1821
1.72
9.62
2.7
3.0
1460.75
1519.44
ng/l
0.08
232
1555
223
1515
1.73
9.31
3.1
3.1
710.75
95.85
e6/l
0.61
188
1164
451
5139
0.57
8.81
4.2
5.0
6.05
6.07
mmol/l
0.11
391
4614
21
48
4.49
8.67
1.0
1.5
—
—
—
0
0
21
48
4.49
8.67
1.0
1.5
—
—
—
0
0
322
2445
1.65
8.64
4.5
3.7
0.00
0.00
estimate
0.50
123
438
167
2415
0.58
8.22
1.8
2.1
80.60
94.11
pmol/l
3.62
104
1213
107
607
1.92
7.97
1.7
1.8
—
—
—
0
0
23
61
3.88
7.86
1.1
1.4
124.74
62.61
pmol/l
3.85
23
61
25
72
3.57
7.61
1.3
6.0
730.60
530.30
iu/ml
—
5
10
38
142
2.78
7.55
1.3
1.3
—
—
—
0
0
21
54
3.99
7.48
1.1
1.2
—
—
—
0
0
21
54
3.99
7.48
1.1
1.2
—
—
—
0
0
21
54
3.99
7.48
1.1
1.2
—
—
—
0
0
375
3023
1.60
7.40
3.2
3.0
99.69
48.03
u/l
3.60
350
2746
106
614
1.87
7.38
1.7
1.8
—
—
—
0
0
63
303
2.20
7.32
2.5
2.3
2.98
15.09
nmol/l
23.42
55
263
121
1863
0.57
7.29
2.2
3.2
6.94
7.56
mmol/l
0.87
91
1561
198
1377
1.64
7.22
3.1
3.0
0.81
0.41
e6/l
1.51
168
1039
109
645
1.83
7.09
5.9
6.5
5.12
5.13
kpa
0.03
104
618
109
645
1.83
7.09
5.9
6.5
12.12
11.42
kpa
0.63
102
617
13
13
10.18
7.06
4.3
1.2
440.00
72.54
nmol/l
0.95
13
13
20
52
3.94
7.03
1.2
1.3
—
—
—
0
0
20
53
3.86
6.85
1.2
1.2
—
—
—
0
0
20
53
3.86
6.85
1.2
1.2
—
—
—
0
0
108
644
1.82
6.84
5.9
6.5
2.53
1.32
mmol/l
2.45
78
509
121
1836
0.58
6.79
2.3
3.2
1077.34
189.68
mg/l
0.63
74
1177
131
1930
0.59
6.49
3.0
3.9
12.19
7.72
mg/mmol
0.44
78
1230
412
4705
0.64
6.31
4.8
4.5
2.00
2.25
mu/l
0.45
361
4215
9
5
18.23
6.28
1.4
1.4
—
—
—
0
0
583
5380
2.17
6.07
33.2
16.5
137.71
139.77
mmol/l
38.95
569
5222
15
25
6.12
6.03
1.5
1.5
—
—
—
0
0
15
25
6.12
6.03
1.5
1.5
—
—
—
0
0
583
5388
2.14
5.91
33.2
16.6
4.04
4.00
mmol/l
2.56
570
5225
12
15
8.13
5.86
1.3
1.1
—
—
—
0
0
14
23
6.20
5.72
1.2
1.1
—
—
—
0
0
14
23
6.20
5.72
1.2
1.1
—
—
—
0
0
202
1480
1.54
5.67
6.0
2.7
35.93
34.47
u/l
0.19
196
1409
16
32
5.10
5.59
1.4
1.4
—
—
—
0
0
43
838
0.48
5.36
1.2
1.3
49.01
38.32
iu/ml
0.21
14
257
41
812
0.47
5.34
1.1
1.3
14.21
12.82
u/ml
0.04
11
280
26
96
2.78
5.33
1.3
1.2
—
—
—
0
0
11
15
7.44
5.16
1.3
1.1
—
—
—
0
0
11
15
7.44
5.16
1.3
1.1
—
—
—
0
0
47
232
2.11
5.15
1.5
2.3
217.98
533.28
ug/l
0.89
42
214
101
672
1.60
4.22
1.8
2.5
22.18
23.42
%
0.41
90
566
12
25
4.87
4.20
1.3
1.2
—
—
—
0
0
13
30
4.40
4.14
1.6
1.2
41.80
32.09
u/l
0.38
13
20
58
335
1.81
4.08
1.8
1.6
—
—
—
0
0
197
2479
0.70
4.08
2.4
2.3
—
—
—
0
0
58
950
0.57
4.07
1.1
1.2
1.25
1.63
u/ml
0.31
22
265
10
18
5.63
3.98
1.4
2.0
—
—
—
0
0
41
215
1.97
3.87
2.1
3.0
4.02
4.42
pmol/l
1.48
36
181
105
720
1.55
3.85
1.8
2.4
2.07
2.27
g/l
2.84
99
661
49
276
1.84
3.75
5.2
3.4
49.86
48.66
%
0.13
49
271
572
5378
1.71
3.67
22.4
9.3
26.15
25.42
u/l
0.34
557
5133
19
73
2.65
3.67
4.3
5.0
9.29
7.60
mmol/l
0.69
14
60
114
806
1.51
3.63
1.9
2.4
10.66
12.98
umol/l
3.20
108
739
178
1377
1.41
3.53
1.6
2.2
3.95
2.95
mg/l
3.22
157
1164
69
438
1.65
3.49
6.9
5.8
1.58
1.49
mmol/l
0.25
69
430
105
1446
0.67
3.43
1.6
1.5
16.99
20.72
nmol/l
1.83
90
1204
79
522
1.59
3.40
4.1
3.1
3.14
2.23
mmol/l
1.08
62
440
584
5547
1.75
3.27
46.1
20.1
255.57
241.43
e9/l
3.98
568
5371
584
5548
1.75
3.25
46.1
20.1
3.97
4.48
e12/l
82.00
565
5346
584
5549
1.75
3.24
46.3
20.1
35.84
40.18
%
42.87
542
5080
584
5550
1.75
3.22
46.4
20.2
119.27
135.74
g/l
96.74
573
5436
78
525
1.55
3.11
4.1
3.1
5.67
5.84
kpa
0.65
78
508
17
68
2.54
3.06
1.6
1.2
—
—
—
0
0
149
1145
1.40
3.03
5.1
4.1
1.01
1.02
kg/l
1.58
29
161
5
5
10.07
2.98
1.0
1.2
—
—
—
0
0
11
291
0.37
2.96
2.2
1.9
—
—
—
0
0
8
18
4.49
2.80
1.6
1.4
—
—
—
0
0
8
18
4.49
2.80
1.6
1.4
—
—
—
0
0
7
14
5.04
2.73
1.1
1.1
17.86
42.67
%
—
7
9
10
30
3.37
2.61
1.8
1.4
1.40
3.38
u/field
—
5
21
8
210
0.37
2.59
1.3
1.5
—
—
—
0
0
72
501
1.49
2.49
2.6
2.3
9.55
8.66
umol/l
0.14
65
429
25
133
1.92
2.34
1.6
2.2
128.75
132.88
g/l
0.34
20
101
345
3819
0.79
2.33
4.5
3.6
15.36
15.00
pmol/l
1.65
307
3409
7
188
0.37
2.30
1.3
1.5
—
—
—
0
0
28
165
1.73
1.94
1.1
1.3
40.23
48.71
mg/l
0.35
19
136
28
165
1.73
1.94
1.1
1.3
32.52
34.03
mg/l
0.05
19
136
391
4228
0.80
1.94
34.0
15.8
15.45
15.34
%
0.25
382
4141
0
51
0.00
1.89
0.0
1.7
—
—
—
0
0
0
52
0.00
1.89
0.0
1.0
—
625.19
—
0
31
0
52
0.00
1.89
0.0
1.0
—
47.60
—
0
30
31
486
0.62
1.86
1.2
1.4
—
—
—
0
0
61
437
1.44
1.86
4.5
2.6
4.18
4.49
kpa
0.97
61
420
5
12
4.19
1.82
1.2
1.3
—
—
—
0
0
19
101
1.91
1.82
1.2
1.7
—
—
—
0
0
9
36
2.52
1.74
1.3
1.5
—
—
—
0
0
6
19
3.18
1.66
1.2
1.6
562.67
946.84
e6/l
—
6
19
21
351
0.58
1.65
2.4
2.6
—
20.09
—
0
12
21
120
1.78
1.64
4.8
3.6
20.23
27.87
mg/l
—
9
80
10
44
2.29
1.56
2.0
2.3
—
—
—
0
0
8
33
2.44
1.54
1.6
2.5
—
—
—
0
0
75
577
1.34
1.53
2.2
2.5
4.41
7.81
ug/l
2.51
62
496
180
2074
0.81
1.53
1.6
2.2
79.16
78.90
nmol/l
0.04
165
1789
5
15
3.35
1.52
1.6
1.5
—
—
—
0
0
5
15
3.35
1.52
1.6
1.5
—
—
—
0
0
6
21
2.87
1.51
1.0
1.1
—
—
—
0
0
9
177
0.50
1.42
1.3
1.4
0.00
0.50
g/l
—
9
155
15
81
1.87
1.41
3.5
2.4
4.14
4.08
mmol/l
0.23
15
81
15
81
1.87
1.41
3.5
2.4
104.60
104.94
mmol/l
0.08
15
81
94
763
1.27
1.32
15.5
7.0
—
—
—
0
0
32
454
0.69
1.25
1.4
1.7
1.97
1.60
%
0.48
25
370
20
303
0.65
1.10
1.2
1.4
—
55.45
—
0
15
6
123
0.48
1.06
1.7
1.8
—
—
—
0
0
121
1037
1.21
1.06
1.6
1.6
1.85
1.32
mg/l
0.98
96
796
71
864
0.80
1.01
3.5
2.6
1.25
1.19
e6/l
0.05
43
496
9
159
0.56
0.99
1.3
1.4
0.00
0.00
g/l
—
9
148
146
1281
1.18
0.99
1.7
1.7
418.08
9615818.30
pmol/l
0.78
121
1040
5
23
2.18
0.98
2.2
1.3
316.40
201.91
u/l
—
5
23
18
116
1.57
0.97
1.7
2.6
1.42
1.69
mg/l
0.86
18
103
5
105
0.47
0.89
1.0
1.1
—
—
—
0
0
53
428
1.26
0.83
4.3
2.2
63.65
63.09
ml/min/173m2
0.03
17
170
9
147
0.61
0.80
1.3
1.3
0.00
0.00
g/l
—
9
139
9
150
0.59
0.79
1.3
1.3
0.00
0.00
g/l
—
9
140
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
5
98
0.51
0.78
1.2
1.3
—
—
—
0
0
11
171
0.64
0.73
1.8
1.9
—
—
—
0
0
12
177
0.67
0.64
1.0
1.1
—
—
—
0
0
69
800
0.85
0.64
3.8
2.8
0.59
2.28
e6/l
4.34
41
434
46
551
0.82
0.61
3.0
3.1
222.05
223.51
ng/l
0.01
40
512
47
561
0.82
0.60
1.4
1.4
—
—
—
0
0
0
22
0.00
0.59
0.0
1.9
—
—
—
0
0
9
61
1.48
0.54
1.6
1.4
—
—
—
0
0
9
63
1.43
0.52
1.1
1.3
—
—
—
0
0
103
1125
0.90
0.43
3.0
4.1
107.22
485.55
ng/l
3.21
82
948
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
1968.44
—
0
16
0
16
0.00
0.41
0.0
1.0
—
111.55
—
0
11
0
18
0.00
0.40
0.0
1.9
—
51.98
—
0
18
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
243
2318
1.08
0.40
9.4
4.0
20.84
2.03
ug/l
7.91
226
2053
7
104
0.67
0.39
1.0
1.3
—
—
—
0
0
12
159
0.75
0.39
1.3
1.4
—
—
—
0
0
8
113
0.70
0.37
1.3
1.2
—
13.46
—
0
7
5
77
0.65
0.36
1.0
1.1
—
—
—
0
0
5
80
0.62
0.35
1.0
1.1
—
—
—
0
0
7
98
0.71
0.31
1.1
1.4
—
—
—
0
0
122
1290
0.93
0.27
3.8
2.7
1.46
0.74
ug/l
4.13
94
901
19
160
1.19
0.25
1.7
2.2
92.59
85.56
ug/min
—
9
93
19
223
0.85
0.24
1.2
1.4
—
—
—
0
0
7
95
0.73
0.22
1.0
1.5
—
—
—
0
0
13
107
1.22
0.21
1.5
2.1
259.54
195.58
%
1.06
13
102
16
135
1.19
0.21
1.1
1.1
—
—
—
0
0
16
135
1.19
0.21
1.1
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
8
105
0.76
0.21
1.4
1.4
—
—
—
0
0
8
105
0.76
0.21
1.4
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
9.40
—
0
14
5
70
0.71
0.16
1.0
1.2
—
164.13
—
0
26
22
241
0.91
0.12
3.0
3.3
23.70
24.44
mmol/l
0.26
22
232
192
1880
1.03
0.11
6.6
3.9
23.81
24.06
%
0.07
129
914
123
1195
1.04
0.11
2.0
1.8
1314.12
1179.88
nmol/l
0.87
103
903
136
1395
0.97
0.10
2.6
2.5
331.73
8311.87
umol/l
6.06
117
1188
14
125
1.12
0.10
1.5
1.9
94.50
86.85
%
0.58
14
119
5
64
0.78
0.08
4.6
3.5
—
—
—
0
0
7
65
1.08
0.08
1.6
1.7
395.43
264.09
mu/l
—
7
57
17
184
0.92
0.07
1.1
1.3
—
—
—
0
0
382
3792
1.02
0.06
3.3
4.2
25.34
12.48
mm/h
17.34
336
3439
41
427
0.96
0.06
2.3
3.5
118.00
88.85
ng/l
0.37
34
372
71
729
0.97
0.06
3.1
5.1
33.13
32.64
%
0.14
53
474
11
121
0.91
0.06
1.2
1.5
—
—
—
0
0
21
199
1.06
0.04
1.3
1.7
—
151.67
—
0
12
478
4763
1.01
0.04
33.8
12.4
79.24
75.02
ml/min/173m2
4.31
430
3847
13
138
0.94
0.02
2.0
1.3
753.15
510.48
mg/l
0.37
13
127
201
2017
0.99
0.00
2.0
2.7
545.38
135.03
ug/l
7.27
183
1826
10
101
0.99
0.00
2.0
1.5
—
—
—
0
0
24
241
1.00
0.00
1.1
1.2
177.66
109.18
iu/ml
—
10
93
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
9
0.00
0.00
0.0
2.9
—
129.67
—
0
9
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
7.56
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
49
1.02
-0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
25.90
—
0
6
0
5
0.00
-0.00
0.0
5.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
101.50
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
117.60
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
9.58
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_SECONDARY_NAS – Secondary malignant neoplasm of other and unspecified sites
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).